venous distention, palpable lymphadenopathy, Raynaud's phenomenon, or skin eruptions. Laboratory investigation revealed microcytic anemia and elevation of the erythrocyte sedimentation rate (ESR), levels of D-dimer, fibrin degradation product (FDP), lactate dehydrogenase (LDH), and C-reactive protein (CRP), while renal and thyroid function tests were normal (Table 1) T A B L E 1 Laboratory data obtained at our hospital on admission by day 53 (Figure 1 ). CH50 was restored to 36.3 U/mL, and her initial complaints, bilateral lower extremity edema, and hand grip weakness also disappeared. After the dosage of prednisolone was tapered down, she was discharged on day 142.
| DISCUSSION
Most autoimmune diseases commonly occur before old age. SLE is a typical example, which predominantly affects women with a high incidence during childbearing age and steep decline after menopause. The onset of SLE in patients over the age of 50 is uncommon, constituting 2%-20% of all patients with SLE. 6 Various researchers have examined differences between early-onset SLE (20s, 30s, and 40s) and late-onset SLE (over the age of 50), and the age at onset has been recognized as a factor associated with the clinical expression of SLE. 2, 6, 7 Among several clinical manifestations of SLE, dermatological symptoms such as malar rash and photosensitivity are less frequent in late-onset SLE patients (malar rash: 40.0% opposed to 73.3%, photosensitivity: 36.7%
opposed to 76.6%). 6, 7 Lupus nephritis is also less common (6.6% vs 46.6%). 6 On the other hand, serositis and cytopenia are more frequently observed in late-onset SLE patients. 7, 8 Among laboratory manifestations of SLE, lower anti-Sm antibody prevalence is one of the characteristic features of late-onset SLE patients (10.5% vs 29.9%). 2, 7 In our case, as well, the patient developed severe serositis, while no skin rash or kidney dysfunction was seen. Anti-Sm antibody was not detected although ANA and antidsDNA antibodies were strongly positive. In the course of aging, the immune system undergoes continual functional changes. 9 For example, the number of circulating B cells decreases with age, and transcriptional changes in B cells lead to reduced ability to generate higher-affinity antibodies. 10 Although it is highly possible that age-dependent changes and/or abnormalities of the immune system may be responsible for the characteristic features of lateonset SLE patients, further investigation is necessary to uncover the mechanisms involving these features.
| CONCLUSION
We herein report a case of very-late-onset SLE, in which serositis was the most drastic clinical manifestation. Patients with late-onset SLE sometimes show atypical clinical features, which make it difficult to reach the correct diagnosis. Pleural effusion is commonly observed in several kinds of diseases, including heart failure, malignancy, and infection. In the primary care setting, it is critical to determine the initial strategy against rapid accumulation of pleural effusion, especially when it affects the patient's respiratory status.
This case demonstrates that late-onset SLE should be considered in the differential diagnosis of rapid accumulation of pleural effusion in the elderly. In addition, investigation into late-onset SLE has become much more important as aging of the general population continues. We hope this case presentation will add to the clinical knowledge about very-lateonset SLE and provide insight into autoimmune diseases in the elderly.
